MedTrace Logo

Apraxia in Parkinson's Disease Patients With Deep Brain Stimulation

NCT04725773 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2025-07-16

No results posted yet for this study

Summary

Deep brain stimulation (DBS) of the subthalamic nucleus or globus pallidus internus can improve motor symptoms Parkinson's disease (PD). However, it is not known whether DBS can help reduce the signs and symptoms of the limb-kinetic, ideomotor or ideational apraxia associated with PD or if apraxia can exist as a stimulation induced side effect from DBS therapy. In this study, we look to conduct a pilot study to examine the feasibility of characterizing the prevalence of apraxia in PD patients with chronic, stable DBS.

Conditions

  • Deep Brain Stimulation
  • Parkinson Disease
  • Apraxia, Motor

Interventions

DEVICE

Deep brain stimulation effect on apraxia

We will evaluate the effect of DBS on apraxia

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Bhavana Patel, DO · University of Florida

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2024-01-28
Completion
2024-01-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04725773 on ClinicalTrials.gov